🔎 Trials Near Me

Utama › Keadaan Pasca-COVID (Long COVID) › Minnesota

Kajian klinikal Keadaan Pasca-COVID (Long COVID) di Minnesota

6 kajian untuk Keadaan Pasca-COVID (Long COVID) sedang mencari peserta di lokasi di Minnesota.

Teks kajian rasmi (Bahasa Inggeris)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Saint Paul
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

  • University of Minnesota, Minneapolis
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06631287

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

  • Mankato Clinic ( Site 3842), Mankato
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06667700

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

  • Mayo Clinic Rochester, Rochester
Mengambil pesertaFasa 3
Semua umur · Semua jantina · Dikemas kini 23 Jun 2026 · NCT03808922

A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae

  • Mayo Clinic Minnesota, Rochester
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Mei 2026 · NCT06006884

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

  • Childrens Hospitals and Clinics of Minnesota, Minneapolis
Mengambil pesertaFasa 3
Umur 0 hingga 17 · Semua jantina · Dikemas kini 17 Jul 2025 · NCT05261139

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.